Hypermacas Looks To Marketing To Remain Leader In Brazil Drug Market
This article was originally published in PharmAsia News
Executive Summary
Brazil's Hypermarcas, which was the biggest seller among the country's drug makers in March, says it plans to maintain the lead by spending more on marketing and maintaining annual growth a few points above 10%.